logo
  

Coca-Cola Lifts FY22 Forecast - Update

While reporting higher financial results for the third quarter on Tuesday, beverages giant Coca-Cola Co. (KO) raised its fiscal 2022 outlook for comparable earnings growth and organic revenue growth.

In pre-market activity on the NYSE, Coca-Cola shares were gaining around 2.8 percent to trade at $59.20.

For fiscal 2022, the company now expects to deliver comparable comparable earnings per share growth of 6 percent to 7 percent from last year's $2.32 per share, with a 9 percent currency headwind. Comparable currency neutral earnings per share growth of 15 percent to 16 percent.

Previously, the company expected comparable earnings to grow in a range of 5 to 6 percent from last year, with a 9 percent currency headwind.

Further, the company now expects to deliver organic revenue growth of 14 percent to 15 percent, with a 7 percent currency headwind and 2 percent tailwind from acquisitions and divestitures. The earlier projected organic revenue growth was 12 to 13 percent, with a 6 percent currency headwind and 2 percent tailwind from acquisitions and divestitures.

For the fourth quarter, comparable net revenues are expected to include an 8 percent currency headwind, and comparable earnings per share is expected to include 9 percent currency headwind.

For fiscal 2023, comparable net revenues are expected to include an approximate 5 percent to 6 percent currency headwind, and comparable earnings per share is expected to include an approximate 7 percent to 8 percent currency headwind.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Health insurer Humana Inc. reported Wednesday a net loss for the fourth quarter that slightly widened from last year, hurt primarily by charges associated with productivity initiatives, despite 6.6 percent revenue growth. Adjusted earnings for the quarter topped analysts' expectations, while quarterly revenues missed it by a whisker. South Plainfield, New Jersey-based Two Rivers Coffee is recalling its peanut butter single serve hot chocolate pods citing an undeclared peanut allergen, the U.S. Food Drug Administration said. The recall involves peanut butter single serve hot chocolate pods distributed as "Brooklyn Bean Peanut Butter Cup Hot Cocoa", "Pingo Peanut Butter Cookie Hot Chocolate" and ... Shares of Novartis AG were losing around 2 percent in the early morning trading in Switzerland after the drug major reported Wednesday sharply lower profit in its fourth quarter with weak sales as well as the absence of prior year's hefty Roche income. Adjusted earnings, however, topped market estimates, while top line missed their view. Further, the company announced higher dividend...
Follow RTT